Gastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant Melanoma

NCT07428252 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Malignant Melanoma

Interventions

DRUG: PD-1 inhibitors
DRUG: PD-1 and CTLA-4 inhibitors

Sponsor

Institute of Oncology Ljubljana